USD 165.52
Price
0.88
(0.53%)
Day Change
|
|
---|
JNJ, the overall quality is good (Quality = 77) and the timing to buy is ...(Sign In to See)...
- Signal
- OUTPERFORM
- Signal Description
- Company financial health is Good
- Reason
-
ROE is decreasing significantly
ROA is too relatively low compare to ROE
Current growth of ROA was below our criteria.
In details, quality factors are not quite good , financial health is not quite good , and ability to make profit is very good , ...
Quality Factors |
|
57% |
In Recommendations? | Not in any sections |
Select Rate | 0.22 From 30 days period |
Watch Rate | 0.25 From 30 days period |
Social Score | 100 |
Magic Formula Rank by ROA |
620
|
Magic Formula Rank by ROE |
620
|
Magic Formula Rank by ROIC |
1113
|
Price | 165.52 |
PBV / Sector |
5.57 / 17.03
|
Earning Per Share | 6.60 |
PE / Sector |
25.08 / 42.76
|
PEG or PE/Growth / Sector |
0.97 / 1.58
|
Average 1M Daily Value |
896.93 M
|
Average 1W Daily Value |
937.69 M
|
Timing Factors |
|
57% |
Financial Health |
|
58% |
Ability to Make Profit |
|
81% |
Return to Investors |
|
33% |
Registration Details |
Analyze Date | 2024-09-14 18:48:47 |
Symbol | JNJ |
Name | JOHNSON & JOHNSON |
Sector | Healthcare >> Drug Manufacturers - General |
Market | NYSE |
Listed Shares | 2,407.24 M |
Par Value | N/A |
Calculated From | Quarter |
Sign | N/A |
Market Cap (M.USD) / Sector Average | 398,446.36 / 223,367.13 |
News, Concensus, ... |
Estimation Consensus | See at WSJ.com |
Full details | See at WSJ.com |
Chart | See in Chart feature |
News | See at Yahoo Finance |